Prostate Cancer Drug Degarelix Rapidly Treats Pedophilic Disorder
Degarelix, an advanced prostate cancer drug, rapidly reduced the risk of committing child sexual abuse among men with pedophilic disorder, a phase 2 trial in JAMA Psychiatry found.
Source: JAMA - Category: General Medicine Source Type: research
More News: Cancer | Cancer & Oncology | Child Abuse | Children | General Medicine | Prostate Cancer | Psychiatry | Sexual Abuse | Substance Abuse